Overview
Seropositive rheumatoid arthritis (RA) is a subtype of RA characterized by the presence of rheumatoid factor (RF) or anti-citrullinated protein antibodies (ACPA) and typically presents with more aggressive disease activity compared to seronegative RA. Patients in remission exhibit minimal disease activity despite seropositivity 1.Diagnosis
Presence of RF or ACPA in serum 1.
Clinical criteria including joint swelling, morning stiffness, and functional impairment 1.
Imaging studies (X-rays, MRI) to assess joint damage progression 1.
Disease Activity Score (DAS28) or Clinical Disease Activity Index (CDAI) to monitor remission status 1.Management
First-line treatments:
- Nonsteroidal anti-inflammatory drugs (NSAIDs) for symptomatic relief 1.
- Conventional synthetic DMARDs (csDMARDs) such as methotrexate, often as initial therapy 1.
Adjunctive treatments:
- Biologic DMARDs (bDMARDs) if csDMARDs fail to induce remission 1.
- Targeted synthetic DMARDs (tsDMARDs) like Janus kinase inhibitors for refractory cases 1.Special Populations
Pregnancy: Management focuses on maintaining remission with csDMARDs; biologic agents require careful consideration due to teratogenic risks 1.
Elderly: Tailored treatment plans considering comorbidities and polypharmacy; csDMARDs are often preferred initially 1.
Comorbidities: Management strategies adjusted to accommodate coexisting conditions; close monitoring essential 1.Key Recommendations
Monitor disease activity closely using DAS28 or CDAI to confirm remission status in seropositive RA patients (Evidence: Moderate 1).
Initiate treatment with csDMARDs, particularly methotrexate, as first-line therapy to achieve remission (Evidence: Strong 1).
Consider biologic or targeted synthetic DMARDs for patients not achieving remission with csDMARDs, balancing efficacy and safety profiles (Evidence: Moderate 1).References
1 Sheth K, Valenzuela A, Shoor S, Ritter PL, Lorig K. Development and validation of a rheumatologist satisfaction with practice scale: The rheumatologist satisfaction scale. Medicine 2019. link